These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36579401)

  • 21. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
    Li Y; Luo Y; Hu Y; Zhu DD; Zhang S; Liu ZJ; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 Jul; 20(14):4316-22. PubMed ID: 22710102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH).
    He X; Reeve AM; Desai UR; Kellogg GE; Reynolds KA
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3093-102. PubMed ID: 15273125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
    Shamim A; Abbasi SW; Azam SS
    J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the research of β-ketoacyl-ACP synthase III (FabH) inhibitors.
    Zhang HJ; Li ZL; Zhu HL
    Curr Med Chem; 2012; 19(8):1225-37. PubMed ID: 22257054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of beta-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli.
    Heath RJ; Rock CO
    J Biol Chem; 1996 May; 271(18):10996-1000. PubMed ID: 8631920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, substrate specificity, and inhibition of the Streptococcus pneumoniae beta-ketoacyl-acyl carrier protein synthase III (FabH).
    Khandekar SS; Gentry DR; Van Aller GS; Warren P; Xiang H; Silverman C; Doyle ML; Chambers PA; Konstantinidis AK; Brandt M; Daines RA; Lonsdale JT
    J Biol Chem; 2001 Aug; 276(32):30024-30. PubMed ID: 11375394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors.
    Luo Y; Zhang LR; Hu Y; Zhang S; Fu J; Wang XM; Zhu HL
    ChemMedChem; 2012 Sep; 7(9):1587-93. PubMed ID: 22811397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antibacterial agents: Hybrid bioisoster derivatives as potential E. coli FabH inhibitors.
    Segretti ND; Serafim RA; Segretti MC; Miyata M; Coelho FR; Augusto O; Ferreira EI
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3988-93. PubMed ID: 27426865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production.
    Misra N; Patra MC; Panda PK; Sukla LB; Mishra BK
    J Biomol Struct Dyn; 2013 Mar; 31(3):241-57. PubMed ID: 22830394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-ketoacyl-acyl carrier protein synthase III (FabH) is essential for bacterial fatty acid synthesis.
    Lai CY; Cronan JE
    J Biol Chem; 2003 Dec; 278(51):51494-503. PubMed ID: 14523010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial FabH Inhibitors with Mode of Action Validated in Haemophilus influenzae by in Vitro Resistance Mutation Mapping.
    McKinney DC; Eyermann CJ; Gu RF; Hu J; Kazmirski SL; Lahiri SD; McKenzie AR; Shapiro AB; Breault G
    ACS Infect Dis; 2016 Jul; 2(7):456-64. PubMed ID: 27626097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.
    Duan YT; Wang ZC; Sang YL; Tao XX; Teraiya SB; Wang PF; Wen Q; Zhou XJ; Ding L; Yang YH; Zhu HL
    Eur J Med Chem; 2014 Apr; 76():387-96. PubMed ID: 24594526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial β-ketoacyl-acyl carrier protein synthase III (FabH) as a target for novel antibacterial agents design.
    Lu XY; Tang J; Zhang Z; Ding K
    Curr Med Chem; 2015; 22(5):651-67. PubMed ID: 25515508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Target identification, and optimization of dioxygenated amide derivatives as potent antibacterial agents with FabH inhibitory activity.
    Chang H; Ji R; Zhu Z; Wang Y; Yan S; He D; Jia Q; Huang P; Cheng T; Wang R; Zhou Y
    Eur J Med Chem; 2024 Feb; 265():116064. PubMed ID: 38159483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
    Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL
    Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y; Zhao CP; Ma HP; Zhao MY; Xue YR; Wang XM; Zhu HL
    Bioorg Med Chem; 2013 Jun; 21(11):3120-6. PubMed ID: 23602519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and biological evaluation of chrysin derivatives as potential FabH inhibitors.
    Li HX; Wang ZC; Qian YM; Yan XQ; Lu YD; Zhu HL
    Chem Biol Drug Des; 2017 Jan; 89(1):136-140. PubMed ID: 27860280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Yang YS; Zhang F; Gao C; Zhang YB; Wang XL; Tang JF; Sun J; Gong HB; Zhu HL
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4619-24. PubMed ID: 22721711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III.
    Zhang YM; Rao MS; Heath RJ; Price AC; Olson AJ; Rock CO; White SW
    J Biol Chem; 2001 Mar; 276(11):8231-8. PubMed ID: 11078736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a new binding site in E. coli FabH using Molecular dynamics simulations: validation by computational alanine mutagenesis and docking studies.
    Ramamoorthy D; Turos E; Guida WC
    J Chem Inf Model; 2013 May; 53(5):1138-56. PubMed ID: 23581389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.